We compared three methods: arteriovenous anastomosis, doxorubicin administration, and combination of anastomosis and doxorubicin, with the intention of designing a simple, stable model of chronic heart failure. Twelve dogs were divided into three groups of four. One group received carotid-jugular anastomosis (Ana series), another group received anastomosis and doxorubicin injection (A/D series), and the last group received only doxorubicin (Dox series). Animals were followed for eight weeks. Fifteen different haemodynamic parameters were tracked and compared to baseline values. After eight weeks, diastolic pressure in the right atrium increased from 3.872.0 mmHg at baseline to 5.375.9 mmHg in the Ana series, to 6.373.3 mmHg in the Dox series and to 8.072.0 mmHg in the A/D series (Po0.05 A/D vs. baseline). Systolic pulmonary wedge pressure increased from 11.672.0 mmHg at baseline to 15.573.4 mmHg in the Ana series, 14.073.7 mmHg in the Dox series and 17.374.2 mmHg in the A/D series (P ¼ NS vs. baseline). Left ventricular ejection fraction decreased from 53.9710% at baseline to 36.175.6% in the Ana series (Po0.05 vs. baseline), 31.575.4% in the Dox series (Po0.05 vs. baseline) and 25.875.8% in the A/D series (Po0.001 vs. baseline, Po0.05 vs. Ana series and Dox series). In conclusion, eight weeks are not enough to produce stable heart failure using arteriovenous anastomosis alone. Doxorubicin administration alone produces a left ventricular failure. However, a combination of both of these interventions provides a more stable model of right-and left-sided heart failure
cardiomyopathy models. For ischaemic cardiomyopathy, coronary artery ligation (Millner et al. 1993 , Kim et al. 2001 ) and coronary microembolization (Kashem et al. 2001 are used. In our previous investigation we used an ameroid constrictor, placed on a branch of the left circumflex artery (Bolotin et al. 2002a) . Rapid pacing is the most commonly used method to create dilated cardiomyopathy (Balaji et al. 1999 , Lainchbury et al. 2000 , Oi et al. 2000 ; however, models created using this method tend to reverse and recover function soon after rapid pacing is terminated (Chekanov et al. 2000) . Hence, this method is not useful in investigating chronic and stable cardiac failure.
The comparison of three different dilative models of heart failure in dogs is the aim of this report: arteriovenous anastomosis alone or in combination with doxorubicin injection, rapid pacing and doxorubicin injection only. We did not use the myocardial ischaemia model in this study because dogs have abundant collateral myocardial circulation and it is difficult to create an ischaemic cardiomyopathy in these animals (Maxwell et al. 1987 ).
Methods
Twelve adult male mongrel dogs (31.973.1 kg) were divided into three groups of four. One group received carotid-jugular anastomosis (Ana group), another group received doxorubicin (Dox group) and the last group received carotid jugular anastomosis and doxorubicin (A/D group).
Animal care
All dogs were obtained two weeks prior to surgery and were examined daily. All animals were treated according to the Principles of Laboratory Animal Care, formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals , revised by the National Academy of Science).
Arteriovenous anastomosis
For all procedures, dogs were anesthetized with sodium pentothal (25 mg/kg i.v.), then intubated and placed on a ventilator (Harvard Apparatus, Southnatick, MA, USA) and maintained on halothane gas anaesthesia (1-2% with 5 L/min O 2 ). Electrocardiogram (EKG) leads were placed and tracings were monitored. Transesophageal echocardiography was performed with the dog in the supine position. The same technician, with over five years of experience with echocardiography in dogs, performed all of the procedures.
To create an arteriovenous anastomosis in the Ana and A/D groups, an incision (7-8 cm) was made on the right side of the neck just above the clavicle along the sternocleidomasteoidian muscle. The right jugular vein and right common carotid artery were isolated, and a side-by-side anastomosis (3-4 cm) was created. Patency of the anastomosis was evaluated by physical exam (auscultation and palpation).
Cefazolin (I-flow Corporation, Lakefront, CA, USA; 1g/i.v.) was given immediately before surgery. After the procedure, the dogs were allowed to recover in the surgical suite until they could be extubated. They were then moved to an isolation cage where they were monitored until fully recovered. Dogs were housed in individual pens during the study. Buprenorphine (Titan Pharmaceuticals Inc, San Francisco, CA, USA; 0.01-0.02 mg/kg i.m.) was given twice daily for 24-48 h as needed for pain. Amoxicillin (United States Pharmacopeia, Rockville, MD, USA; 1500 mg/day p.o.) was given for 10 days after surgery.
At the end of the study, dogs were euthanized using Beuthanasia-D (Schering-Plough Animal Health, Kenilworth, NJ, USA; 1 mL/5 kg i.v.) while under general anaesthesia with halothane (1-2% with 5 L/ min O 2 ).
Doxorubicin administration
The protocol consisted of up to six peripheral weekly i.v. infusions of 1.0 mg/kg of doxorubicin (Sigma, St Louis, MO, USA).
These infusions were given for the Dox group and just after the anastomosis creation surgery in the A/D group.
Monitoring and data collection
Cardiac haemodynamics Right cardiac catheterization was performed in all dogs prior to any drug administration or intervention and again at the end of the study (8 weeks). A Swan-Ganz catheter (Edwards Life Science LLC, Irving, CA, USA) was inserted into the internal jugular vein. The right atrial, right ventricle, pulmonary artery and pulmonary artery wedge pressures were measured.
Echocardiography Two-dimensional echocardiographic studies were performed using a SONOS 2000 echocardiographic system (Hewlett-Packard, Andover, MA, USA) with a 6.0/50 MHz TEE transducer. The echocar-diographic studies were performed at baseline (prior to any drug administration or intervention) in all dogs and repeated two weeks after first intervention, then weekly until the end of the study (8 weeks). All animals were anaesthetized with i.v. Thiopental (Abbott, Chicago, IL, USA; 25 mg/kg) and placed in the supine position. Two to three sets of measurements were taken and the results averaged. The mean value of the three measurements was used to describe the quantitative data for each animal at each data point. The same technician performed all of the studies and the same echocardiographer analysed all of the images.
Statistical analysis
Data were expressed as mean7standard deviation of mean and analysed by repeated measures analysis of variance with multiple comparisons (Scheffe's test). A P value of Laboratory Animals (2007) 0.05 or less was considered to be statistically significant. At baseline, there were no statistically significant differences between the three groups in terms of echocardiographic measurements, heart rate, blood pressure, and intracardiac pressures.
Results

Cardiac haemodynamic results
Right heart pressures (Table 1) The diastolic pressure in the right atrium (RAd) increased from a mean of 3.8 mmHg at baseline to 8 in the A/D group (Po0.05), 5.3 mmHg in the Ana group (P ¼ NS), and 6.5 mmHg in the Dox group (P ¼ NS). The right ventricle (RVd) in the A/D increased from a mean of 3.1 mmHg at baseline to a mean of 7 mmHg (Po0.05). These pressures did change in the other two groups but failed to reach statistical significance. The other right-sided pressures (superior vena cava in systole (SVC), and pulmonary artery pressure (PA)) showed signs of right-sided heart failure but also failed to reach statistical significance (Figures 1-4) .
Left heart pressures (Table 2) The mean cardiac output (CO) also decreased statistically in all three groups, from a mean baseline of 3.8 to 3 in the Ana group (Po0.05), 2.5 in the Dox group (Po0.05), and 2 in the A/D group (Po0.05) to a significant level. The diastolic pulmonary capillary wedge pressure (PWPd) increased in all three groups from a mean baseline of 5.4 mmHg, but only reached statistical significance in the A/D group (11 mmHg). The systolic pulmonary wedge pressure (PWPs) also increased in all three groups from a mean baseline of 11.6 mmHg, but did not reach statistical significance in any group. The left ventricular pressures (LVs) decreased from a baseline mean of 137 to 126 mmHg in the A/D and 118 mmHg in the Dox group, but paradoxically, it increased in the anastomosis group to 163 mmHg. None of these changes in the LV systolic pressures were statistically significant. The LV diastolic pressures deteriorated in all groups from a mean baseline of 5.5 to 4 mmHg in the Ana group (P ¼ NS), 3 mmHg in the A/D group (P ¼ NS), and 1.9 mmHg in the Dox group (P ¼ NS). Aortic pressure (Ao) changes followed the same pattern as LV pressures and also failed to reach statistical significance.
Echocardiographic results (Table 3) All dogs in all three groups developed significant left-sided heart failure. The left ventricle ejection fraction (LVEF) decreased from a mean of 62% at baseline to 36% in the Ana group, 30% in the Dox group and 26% in the A/D group at the end of the eightweek intervention (Po0.05 in all 3 groups). The left ventricle end-systolic volume (MVol-S) increased from 22.5 mL to a statistically significant level in the Dox (31.8 mL) and A/D (32.9 mL) groups. It also increased in the Ana group (28.1 mL) but this increase was not statistically significant. Heart rate increased from a mean baseline of 99 to 108 bpm in the Ana group (P ¼ NS), 155 bpm in the A/D group (Po0.05) and 143 bpm in the Dox group (Po0.05).
Discussion
Doxorubicin (adriamycin) is one of the most effective cardiotoxic agents for creating a long-term, stable dilated cardiomyopathy (Cheng et al. 1992 , Shah et al. 1997 , Toyoda et al. 1998 , Christiansen et al. 2002 , Monnet 2002 . Pathogenesis of doxorubicin toxicity has been studied over the last 25 years. It is found to be multifactorial. It generally leads to degenerative changes in the myocardium with myofibril loss, altered synthesis of nucleic acids (Rosenoff et al. 1975 ) and mitochondrial respiration (Iwamoto et al. 1974) , formation of free radicals (Myers et al. 1977 ) and release of histamine and catecholamine (Bristow et al. 1981) . Intracoronary doxorubicin injection may be used for rapid formation of heart failure (Shah et al. 2000) . Christiansen et al. (2002) showed that weekly administration of adriamycin increased central venous pressure, mean pulmonary artery pressure and pulmonary wedge pressure significantly, and markedly decreased left ventricular ejection fraction. In our investigation, we also witnessed a statistically significant change in haemodynamics after doxorubicin injection alone. Left ventricular ejection fraction decreased from 53.9710.0 to 31.575.4% (Po0.05).
Other toxic agents can induce toxic cardiomyopathy, although they are rarely used. These include imipramine (Lucas et al. 1992) , furazolidone (van Vleet & Ferrans 1983) , emitine (Khan et al. 1983) , cyclophosphamide (Hopkins et al. 1982) and high concentration of glucose (Dutta et al. 2002) .
Laboratory Animals (2007) 41 Canine models of heart failure 67 Carotid jugular arteriovenous shunt has frequently been used to induce toxic cardiomyopathy (Ozek et al. 1998 , Wang & Gerdes 1999 , Bolotin et al. 2002a ,b, Kaulbach et al. 2002 . Heart failure was induced in pigs and goats with a significant decrease in left ventricular ejection fraction in evidence for 8-12 weeks post surgery. In our investigation, we performed arteriovenous anastomosis on a dog model. After eight weeks, there was no significant deterioration in right heart function, however, the left ventricular ejection fraction decreased from 53.9710.0 to 36.175.6% (Po0.05). To explain the reason for the deterioration of the ejection fraction while there was no change in the other parameters used to measure heart function, two possibilities could be entertained. Either, carotid-jugular shunt only is not appropriate for creation of chronic heart failure, or the time period was too short to achieve statistically significant results. All of our data documented a tendency for the left or right heart function to deteriorate but not always to a statistically significant level (see Results).
In 2000, we published the results of a study in which we used simultaneous arteriovenous anastomosis and doxorubicin injection to create heart failure in sheep (Chekanov et al. 2000) . We found that this combined method created a stable model of biventricular heart failure (right atrial pressure 2073 vs. 672 mmHg at baseline; pulmonary capillary wedge pressure 1873 vs. 972 mmHg; left ventricular end-diastolic area 15.271.2 vs. 6.470.7 cm 2 ; left ventricular ejection fraction 3876 vs. 6577%). Tessier et al. (2003) reported similar findings in goats. They concluded that arteriovenous anastomosis alone did not produce heart failure. Rather that the combination of arteriovenous fistula and doxorubicin injection provided a simple and stable chronic model of heart failure. They also found that this association allowed for reduction in the required doxorubicin dose as compared with use of doxorubicin alone.
Our data in a series of investigations confirmed that the combination of carotid-jugular shunt and doxorubicin administration produced stable and pronounced bilateral heart failure. However, interestingly, leftsided heart failure in the dog model was more pronounced than in sheep. Left ventricular ejection fraction was 25.875.8% in the dog model (vs. 3876.5% in sheep).
Diastolic function on the right side of the heart deteriorated more than systolic function in the A/D series. Diastolic pressure in the right atrium, right ventricle and pulmonary capillaries showed a statistically significant increase from baseline. Another important finding was that there was no statistically significant difference in right-sided heart failure between the A/D series and the series using Dox or Ana alone. Regardless of the method used (doxorubicin plus anastomosis, doxorubicin alone, or anastomosis alone), the degree of the right-sided heart failure was the same.
Data relating to left ventricular function after doxorubicin administration and carotid-jugular shunt was contradictory. Left ventricular end-systolic volume (LVESV) and area increased, but not to a level that was statistically significant. Left ventricular enddiastolic volume (LVEDV) and area decreased, again, not to a level that was statistically significant; however, due to the decrease in LVEDV and the increase in LVESV, the drop in LVEF was statistically significantly measured from baseline (Po0.001). The decrease in LVEF in the A/D group was greater and statistically significant when compared to the series using Ana alone or the series using Dox alone.
Study limitations
The study sample was small and a power analysis was not performed to prove an n of 4 would adequately detect the difference. A test using low power/a greater n should be done to detect where a significant difference exists. The study data and results were not compared with other studies in the literature.
Conclusion
Eight weeks is not long enough to produce stable heart failure using arteriovenous anastomosis alone. Doxorubicin administration alone can produce a left ventricular failure. However, a combination of both of these interventions provides a more stable model of right-and left-sided heart failure. This model may be useful for testing different surgical methods for treating non-ischaemic cardiomyopathy, but additional studies are required to characterize further this canine model of heart failure.
